{
    "Trade/Device Name(s)": [
        "iHealth BG3 Smart Gluco-Monitoring System"
    ],
    "Submitter Information": "Andon Medical Co., Ltd.",
    "510(k) Number": "K120813",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110017"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JQP"
    ],
    "Summary Letter Date": "November 26, 2012",
    "Summary Letter Received Date": "November 29, 2012",
    "Submission Date": "March 15, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iHealth BG3 Smart Gluco-Monitoring System",
        "iPhone",
        "iPod touch"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry",
        "Capillary action"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "In vitro diagnostic testing"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Meter",
        "Test Strip",
        "Lancet",
        "Control Solution",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for iHealth BG3 Smart Gluco-Monitoring System for quantitative blood glucose measurement using electrochemical biosensor and iOS connectivity",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from various body sites for single-person self-testing by people with diabetes at home; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}